While digestive conditions affect approximately 60 to 70 million in the U.S., many don’t recognize it. A new survey examines misperceptions in gastrointestinal health.
AbbVie’s Rova-T Wins ‘Most Promising Clinical Candidate’ Award award at World Antibody Drug Conjugate Summit.
For the fourth consecutive year, AbbVie has made Working Mother magazine’s list of “100 Best Companies.”
Stay up to date on recent news, articles, and more by subscribing to e-mail alerts for one or more of our news topics.
YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE
Notice
The "Yes" link below will take you out of the AbbVie family of websites.
Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.
The Internet site that you have requested may not be optimized to your screen size.
Do you wish to leave this site?